Trial intelligence / Profile preview

RESCUE-ICH: PPA Cocktail for Edema in Intracerebral Hemorrhage

NCT06863558Phase 3Not yet recruiting

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
May 2025
Primary completion
Mar 2026
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of terazosin, urapidil, propranolol, esmolol in intracerebral hemorrhage (ICH), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start May 2025; status: not yet recruiting.

02

Drugs

terazosinurapidilpropranololesmolol
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on NCT06863558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06863558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call